首页 > 最新文献

Annals of breast surgery : an open access journal to bridge breast surgeons across the world最新文献

英文 中文
Current imaging techniques and impact on diagnosis and survival —a narrative review 当前的成像技术及其对诊断和生存的影响——叙述性综述
P. Steyerová, A. Burgetová
Imaging plays a central role in the detection and assessment of breast cancer. Breast cancer screening programmes have been well established, as even in the era of modern therapies early detection has a major impact on survival. Time interval and method of breast cancer surveillance programme depends greatly on the individual risk factors and a correct selection and/or combination of methods proved to be useful in women with higher than average risk or in women with dense breasts. In women with clinical symptoms, imaging methods provide reliable differentiation between benign and suspicious processes that need to be evaluated with a biopsy. Each of the three basic imaging methods of the breast—mammography, breast ultrasound and magnetic resonance imaging (MRI) has its advantages and limitations. Additionally, appropriate preoperative marking is a mandatory part of imaging that helps transfer the information from imaging to surgery. In this review, we summarize the data on the use of breast imaging in prevention, diagnostics and staging with a clinical perspective. We emphasize the multimodality approach with combined evaluation of all imaging methods and multidisciplinary team work with close cooperation of various medical specialties, which is essential for planning the proper execution of patient management to ensure the best possible outcome. Practical examples are given in a series of clinical scenarios.
成像在乳腺癌的检测和评估中起着核心作用。乳腺癌筛查计划已经建立,因为即使在现代治疗的时代,早期发现对生存也有重大影响。乳腺癌监测计划的时间间隔和方法在很大程度上取决于个体风险因素,正确选择和/或组合方法被证明对风险高于平均水平的妇女或乳房致密的妇女是有用的。在有临床症状的妇女中,影像学方法可可靠地区分良性和可疑病变,需要活检评估。乳腺x线摄影、乳腺超声和磁共振成像(MRI)这三种基本成像方法各有其优点和局限性。此外,适当的术前标记是成像的必要部分,有助于将信息从成像传递到手术。在这篇综述中,我们从临床角度总结了乳腺影像学在预防、诊断和分期中的应用。我们强调综合评估所有成像方法的多模式方法和多学科团队工作,与各医学专业密切合作,这对于规划正确执行患者管理以确保最佳结果至关重要。在一系列临床场景中给出了实际的例子。
{"title":"Current imaging techniques and impact on diagnosis and survival —a narrative review","authors":"P. Steyerová, A. Burgetová","doi":"10.21037/abs-21-22","DOIUrl":"https://doi.org/10.21037/abs-21-22","url":null,"abstract":"Imaging plays a central role in the detection and assessment of breast cancer. Breast cancer screening programmes have been well established, as even in the era of modern therapies early detection has a major impact on survival. Time interval and method of breast cancer surveillance programme depends greatly on the individual risk factors and a correct selection and/or combination of methods proved to be useful in women with higher than average risk or in women with dense breasts. In women with clinical symptoms, imaging methods provide reliable differentiation between benign and suspicious processes that need to be evaluated with a biopsy. Each of the three basic imaging methods of the breast—mammography, breast ultrasound and magnetic resonance imaging (MRI) has its advantages and limitations. Additionally, appropriate preoperative marking is a mandatory part of imaging that helps transfer the information from imaging to surgery. In this review, we summarize the data on the use of breast imaging in prevention, diagnostics and staging with a clinical perspective. We emphasize the multimodality approach with combined evaluation of all imaging methods and multidisciplinary team work with close cooperation of various medical specialties, which is essential for planning the proper execution of patient management to ensure the best possible outcome. Practical examples are given in a series of clinical scenarios.","PeriodicalId":72212,"journal":{"name":"Annals of breast surgery : an open access journal to bridge breast surgeons across the world","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43448337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Pre-pectoral implant-based breast reconstruction after mastectomy: a narrative review 乳房切除术后以胸前假体为基础的乳房重建:一个叙述性的回顾
R. Di Micco, L. Santurro, Gaetano Lapiana, D. Socci, V. Zuber, G. Cisternino, Sara Baleri, Stefano Rottino, R. Ceccarino, O. Gentilini
{"title":"Pre-pectoral implant-based breast reconstruction after mastectomy: a narrative review","authors":"R. Di Micco, L. Santurro, Gaetano Lapiana, D. Socci, V. Zuber, G. Cisternino, Sara Baleri, Stefano Rottino, R. Ceccarino, O. Gentilini","doi":"10.21037/abs-21-147","DOIUrl":"https://doi.org/10.21037/abs-21-147","url":null,"abstract":"","PeriodicalId":72212,"journal":{"name":"Annals of breast surgery : an open access journal to bridge breast surgeons across the world","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42149277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Machine learning techniques for breast cancer diagnosis and treatment: a narrative review 癌症诊断和治疗的机器学习技术:叙述性综述
M. Sugimoto, Shiori Hikichi, M. Takada, Masakazu Toi
Objective: This narrative review describes the recent developments and applications of machine learning (ML), a part of artificial intelligence, concerning breast cancer. Background: The advent of new bioinformatic approaches and artificial intelligence-based computational technologies has led to a shift in the decision-making of oncologists regarding breast cancer diagnostics and treatment processes. Various successful applications of ML on image processing, especially the use of deep neural networks and convolutional neural networks, to detect tumor and lymph nodes regions have been reported. Recent high-throughput molecular quantifications, i.e., quantitative omics techniques have enabled simultaneous monitoring of thousands of molecules to understand the molecular-level pathology. These data, including gene expression, protein, metabolite, and methylation profiling, have been analyzed via deep learning, network analysis, clustering, and dimension reductions to explore intrinsic subtypes and new biomarkers. Clinical-pathological features have been conducted by multivariable analysis to predict various outcomes, e.g., the sensitivity of adjuvant therapy and prognosis. The quantitative relationships among their variables have been visualized as nomograms. To analyze complex structures of a larger number of variables, ML combining multiple clinical-pathological features has been developed to predict the prognosis, metastasis, and treatment outcomes of breast cancer. Methods: We provided the narrative review of ML-related topics especially in the quantitative omics data and clinical-pathological prediction models. Conclusion: ML-based prediction methods are powerful tools and contribute to realizing personalized medicine for breast cancer.
目的:本文叙述人工智能的一部分机器学习(ML)在癌症方面的最新发展和应用。背景:新的生物信息学方法和基于人工智能的计算技术的出现导致肿瘤学家在乳腺癌症诊断和治疗过程中的决策发生了转变。ML在图像处理中的各种成功应用,特别是使用深度神经网络和卷积神经网络来检测肿瘤和淋巴结区域,已经有报道。最近的高通量分子定量,即定量组学技术,使人们能够同时监测数千个分子,以了解分子水平的病理学。这些数据,包括基因表达、蛋白质、代谢产物和甲基化谱,已经通过深度学习、网络分析、聚类和降维进行了分析,以探索内在的亚型和新的生物标志物。临床病理特征已通过多变量分析进行预测,以预测各种结果,例如辅助治疗的敏感性和预后。变量之间的定量关系已被可视化为列线图。为了分析大量变量的复杂结构,已经开发了结合多种临床病理特征的ML来预测癌症的预后、转移和治疗结果。方法:我们提供了ML相关主题的叙述性综述,特别是在定量组学数据和临床病理预测模型方面。结论:基于ML的预测方法是实现癌症个性化用药的有力工具。
{"title":"Machine learning techniques for breast cancer diagnosis and treatment: a narrative review","authors":"M. Sugimoto, Shiori Hikichi, M. Takada, Masakazu Toi","doi":"10.21037/abs-21-63","DOIUrl":"https://doi.org/10.21037/abs-21-63","url":null,"abstract":"Objective: This narrative review describes the recent developments and applications of machine learning (ML), a part of artificial intelligence, concerning breast cancer. Background: The advent of new bioinformatic approaches and artificial intelligence-based computational technologies has led to a shift in the decision-making of oncologists regarding breast cancer diagnostics and treatment processes. Various successful applications of ML on image processing, especially the use of deep neural networks and convolutional neural networks, to detect tumor and lymph nodes regions have been reported. Recent high-throughput molecular quantifications, i.e., quantitative omics techniques have enabled simultaneous monitoring of thousands of molecules to understand the molecular-level pathology. These data, including gene expression, protein, metabolite, and methylation profiling, have been analyzed via deep learning, network analysis, clustering, and dimension reductions to explore intrinsic subtypes and new biomarkers. Clinical-pathological features have been conducted by multivariable analysis to predict various outcomes, e.g., the sensitivity of adjuvant therapy and prognosis. The quantitative relationships among their variables have been visualized as nomograms. To analyze complex structures of a larger number of variables, ML combining multiple clinical-pathological features has been developed to predict the prognosis, metastasis, and treatment outcomes of breast cancer. Methods: We provided the narrative review of ML-related topics especially in the quantitative omics data and clinical-pathological prediction models. Conclusion: ML-based prediction methods are powerful tools and contribute to realizing personalized medicine for breast cancer.","PeriodicalId":72212,"journal":{"name":"Annals of breast surgery : an open access journal to bridge breast surgeons across the world","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48436908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Abscess/infections/periareolar mastitis 脓肿/感染/乳腺炎
C. Pesce, K. Yao
: Breast infections can be considered lactational or nonlactational, and the guiding principle in treating breast infection is to give antibiotics as early as possible to stop abscess formation. Lactational abscesses are usually caused by Staphylococcus aureus, including MRSA, often due to trauma during breastfeeding. A combination of repeated aspirations and oral antibiotics is usually effective at resolving abscess formation and is the current treatment of choice. Women should be encouraged to continue breastfeeding. Rarely, surgical drainage of lactational abscesses is required, and the development of milk fistula is uncommon. Nonlactational abscess are considered central (periareolar) or peripheral. Periareolar abscesses are common in young women and smokers, and up to half of patients experience recurrent episodes of infection. The underlying cause of recurrent infections is obstructed lactiferous ducts by keratin plugs, and therefore a subareolar abscess will continue to recur unless these ducts are excised by total duct excision. Often, a mammary duct fistula can form due to recurrent infection treated by incision and drainage (I&D), and treatment is again surgical consisting of either opening up the fistula tract and leaving it to granulate or excising the fistula and affected ducts and closing the wound primarily. Peripheral breast abscesses are less common, and most recently treatment has shifted from open surgical drainage to less invasive repeated aspirations using ultrasound-guidance. Advantages to percutaneous aspiration include shorter healing time and improved cosmetic outcomes. For women older than 35 years old and/or at risk for breast cancer, management of breast infections should not forgo recommended screening, and upon resolution of symptoms mammography is recommended.
:乳腺感染可以被认为是哺乳期的或非哺乳期的,治疗乳腺感染的指导原则是尽早使用抗生素来阻止脓肿的形成。哺乳期脓肿通常由金黄色葡萄球菌引起,包括MRSA,通常是由于母乳喂养期间的创伤。反复的愿望和口服抗生素的组合通常能有效地解决脓肿的形成,也是目前的治疗选择。应鼓励妇女继续母乳喂养。很少需要对哺乳期脓肿进行手术引流,而且乳瘘的发生也很少见。非哺乳期脓肿被认为是中心性(乳晕周围)或外周性。乳晕周围脓肿在年轻女性和吸烟者中很常见,多达一半的患者会反复感染。复发性感染的根本原因是角蛋白栓塞阻塞了乳管,因此,除非通过全管切除术切除这些乳管,否则乳晕下脓肿将继续复发。通常,通过切开引流(I&D)治疗的复发性感染会形成乳腺管瘘,治疗方法也是外科手术,包括打开瘘管并使其造粒,或切除瘘管和受影响的导管并主要闭合伤口。外周乳腺脓肿不太常见,最近的治疗方法已从开放式手术引流转向使用超声引导的微创重复穿刺。经皮抽吸的优点包括更短的愈合时间和改善的美容效果。对于35岁以上和/或有患癌症风险的女性,乳腺感染的管理不应放弃建议的筛查,并建议在症状缓解后进行乳房X光检查。
{"title":"Abscess/infections/periareolar mastitis","authors":"C. Pesce, K. Yao","doi":"10.21037/ABS-21-49","DOIUrl":"https://doi.org/10.21037/ABS-21-49","url":null,"abstract":": Breast infections can be considered lactational or nonlactational, and the guiding principle in treating breast infection is to give antibiotics as early as possible to stop abscess formation. Lactational abscesses are usually caused by Staphylococcus aureus, including MRSA, often due to trauma during breastfeeding. A combination of repeated aspirations and oral antibiotics is usually effective at resolving abscess formation and is the current treatment of choice. Women should be encouraged to continue breastfeeding. Rarely, surgical drainage of lactational abscesses is required, and the development of milk fistula is uncommon. Nonlactational abscess are considered central (periareolar) or peripheral. Periareolar abscesses are common in young women and smokers, and up to half of patients experience recurrent episodes of infection. The underlying cause of recurrent infections is obstructed lactiferous ducts by keratin plugs, and therefore a subareolar abscess will continue to recur unless these ducts are excised by total duct excision. Often, a mammary duct fistula can form due to recurrent infection treated by incision and drainage (I&D), and treatment is again surgical consisting of either opening up the fistula tract and leaving it to granulate or excising the fistula and affected ducts and closing the wound primarily. Peripheral breast abscesses are less common, and most recently treatment has shifted from open surgical drainage to less invasive repeated aspirations using ultrasound-guidance. Advantages to percutaneous aspiration include shorter healing time and improved cosmetic outcomes. For women older than 35 years old and/or at risk for breast cancer, management of breast infections should not forgo recommended screening, and upon resolution of symptoms mammography is recommended.","PeriodicalId":72212,"journal":{"name":"Annals of breast surgery : an open access journal to bridge breast surgeons across the world","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48195248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protecting nipple-areolar complex perfusion by devascularization and surgical delay 断流术和延迟手术保护乳头乳晕复合体灌注
Jacqueline Tsai, I. Wapnir
: The greatest challenge to nipple areolar complex (NAC) preservation during mastectomy has been ischemic complications which can range from epidermolysis to complete necrosis. Women with macromastia, ptosis, or smokers are at greater risk for these complications. Additional risk factors associated with ischemia that have been described include mastectomy incision placement, reconstruction type, and other known medical comorbidities. In this manuscript techniques for evaluation of skin perfusion patterns with angiography to aid in optimal incision placements and surgical delay are described. Devascularization of the NAC prior to a nipple sparing mastectomy is a surgical delay technique aimed at preventing irreversible skin ischemia. Devascularization consists of separating the NAC and surrounding skin from the underlying breast tissue. Similar to other surgical delay procedures utilized in other plastic reconstructive procedures, blood inflow through the skin is enhanced as a compensatory mechanism after the first stage devascularization. The first stage NAC devascularization can be performed with a lumpectomy procedure in patients with a newly diagnosed cancer and the second stage completion mastectomy is performed after 3 to 6 weeks later after temporary ischemic changes have resolved. The timing for completion mastectomy can also be adjusted for a later time point if more urgent systemic or locoregional treatment is needed. The utilization of a staged devascularization and delayed nipple sparing mastectomy allows more patients to achieve the desired aesthetic goals of nipple areolar preservation while minimizing ischemic complications, and most importantly does not compromise oncologic safety of the breast cancer patient.
乳头乳晕复合体(NAC)保存在乳房切除术中的最大挑战是缺血性并发症,其范围从表皮松解到完全坏死。患有巨乳症、上睑下垂或吸烟的妇女发生这些并发症的风险更大。与缺血相关的其他危险因素包括乳房切除术切口位置、重建类型和其他已知的医学合并症。在这个手稿技术评估皮肤灌注模式与血管造影,以帮助在最佳切口位置和手术延迟描述。保留乳头乳房切除术前NAC断流术是一种手术延迟技术,旨在防止不可逆的皮肤缺血。断流术包括将NAC和周围皮肤与乳腺组织分离。与其他整形重建手术中使用的其他手术延迟程序类似,在第一阶段断流后,通过皮肤的血液流入作为一种代偿机制得到加强。对于新诊断为癌症的患者,一期NAC断流术可通过乳房肿瘤切除术进行,二期全乳切除术在暂时性缺血改变消退后3 - 6周后进行。如果需要更紧急的全身或局部治疗,完全性乳房切除术的时间也可以调整到更晚的时间点。采用分阶段断流术和延迟乳头保留乳房切除术,可以使更多的患者达到保留乳头乳晕的理想美学目标,同时最大限度地减少缺血性并发症,最重要的是不会损害乳腺癌患者的肿瘤安全性。
{"title":"Protecting nipple-areolar complex perfusion by devascularization and surgical delay","authors":"Jacqueline Tsai, I. Wapnir","doi":"10.21037/ABS-20-111","DOIUrl":"https://doi.org/10.21037/ABS-20-111","url":null,"abstract":": The greatest challenge to nipple areolar complex (NAC) preservation during mastectomy has been ischemic complications which can range from epidermolysis to complete necrosis. Women with macromastia, ptosis, or smokers are at greater risk for these complications. Additional risk factors associated with ischemia that have been described include mastectomy incision placement, reconstruction type, and other known medical comorbidities. In this manuscript techniques for evaluation of skin perfusion patterns with angiography to aid in optimal incision placements and surgical delay are described. Devascularization of the NAC prior to a nipple sparing mastectomy is a surgical delay technique aimed at preventing irreversible skin ischemia. Devascularization consists of separating the NAC and surrounding skin from the underlying breast tissue. Similar to other surgical delay procedures utilized in other plastic reconstructive procedures, blood inflow through the skin is enhanced as a compensatory mechanism after the first stage devascularization. The first stage NAC devascularization can be performed with a lumpectomy procedure in patients with a newly diagnosed cancer and the second stage completion mastectomy is performed after 3 to 6 weeks later after temporary ischemic changes have resolved. The timing for completion mastectomy can also be adjusted for a later time point if more urgent systemic or locoregional treatment is needed. The utilization of a staged devascularization and delayed nipple sparing mastectomy allows more patients to achieve the desired aesthetic goals of nipple areolar preservation while minimizing ischemic complications, and most importantly does not compromise oncologic safety of the breast cancer patient.","PeriodicalId":72212,"journal":{"name":"Annals of breast surgery : an open access journal to bridge breast surgeons across the world","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47293517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Immediate lymphatic reconstruction for breast cancer 乳腺癌症的即时淋巴重建
A. Seth, D. Singhal
Upper extremity lymphedema remains a significant source of morbidity in breast cancer patients despite significant improvements in breast cancer care. The risk of lymphedema is particularly elevated in patients requiring an axillary lymph node dissection and/or adjuvant radiation to treat their disease. Current treatment options for lymphedema, including conservative management or surgery, are limited and are often aimed at improving symptoms and quality of life rather than curing the disease. In this review we describe immediate lymphatic reconstruction, a novel surgical procedure that is done concurrent with axillary lymph node dissection in an effort to prevent the development of breast cancer-related lymphedema. Based on our growing knowledge of the pathophysiology of lymphedema, microsurgical techniques are used at the time of axillary lymph node dissection to perform a lymphovenous bypass between transected, leaking lymphatic channels and an adjacent, small calibre vein in the axilla. Using several objective metrics for shortand longterm surveillance, patients are monitored for the development of postoperative lymphedema. Early outcomes from using this technique have been promising, both in the literature and within our own institutions, demonstrating significant improvements in rates of postoperative lymphedema. However, future study is still required to better understand the long-term efficacy of immediate lymphatic reconstruction.
尽管癌症治疗有了显著改善,但上肢淋巴水肿仍然是癌症患者发病率的重要来源。在需要腋窝淋巴结清扫和/或辅助放疗来治疗疾病的患者中,淋巴水肿的风险尤其高。目前淋巴水肿的治疗选择,包括保守治疗或手术,是有限的,通常旨在改善症状和生活质量,而不是治愈疾病。在这篇综述中,我们描述了即时淋巴重建,这是一种新的外科手术,与腋窝淋巴结清扫同时进行,以防止乳腺癌相关淋巴水肿的发展。基于我们对淋巴水肿病理生理学的日益深入的了解,在腋窝淋巴结清扫时,使用显微外科技术在横断的、渗漏的淋巴管和腋窝相邻的小口径静脉之间进行淋巴静脉搭桥。使用几种短期和长期监测的客观指标,监测患者术后淋巴水肿的发展。在文献和我们自己的机构中,使用这项技术的早期结果都是有希望的,表明术后淋巴水肿的发生率有了显著改善。然而,未来的研究仍然需要更好地了解即时淋巴重建的长期疗效。
{"title":"Immediate lymphatic reconstruction for breast cancer","authors":"A. Seth, D. Singhal","doi":"10.21037/ABS-20-110","DOIUrl":"https://doi.org/10.21037/ABS-20-110","url":null,"abstract":"Upper extremity lymphedema remains a significant source of morbidity in breast cancer patients despite significant improvements in breast cancer care. The risk of lymphedema is particularly elevated in patients requiring an axillary lymph node dissection and/or adjuvant radiation to treat their disease. Current treatment options for lymphedema, including conservative management or surgery, are limited and are often aimed at improving symptoms and quality of life rather than curing the disease. In this review we describe immediate lymphatic reconstruction, a novel surgical procedure that is done concurrent with axillary lymph node dissection in an effort to prevent the development of breast cancer-related lymphedema. Based on our growing knowledge of the pathophysiology of lymphedema, microsurgical techniques are used at the time of axillary lymph node dissection to perform a lymphovenous bypass between transected, leaking lymphatic channels and an adjacent, small calibre vein in the axilla. Using several objective metrics for shortand longterm surveillance, patients are monitored for the development of postoperative lymphedema. Early outcomes from using this technique have been promising, both in the literature and within our own institutions, demonstrating significant improvements in rates of postoperative lymphedema. However, future study is still required to better understand the long-term efficacy of immediate lymphatic reconstruction.","PeriodicalId":72212,"journal":{"name":"Annals of breast surgery : an open access journal to bridge breast surgeons across the world","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44740924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immediate direct-to-implant breast reconstruction with prepectoral vs. subpectoral approach: a narrative review 胸前入路与胸下入路的即刻直接植入乳房重建术:叙述回顾
N. Velotti, N. Rocco, A. Vitiello, Giovanna Berardi, Martina Pontillo, M. Musella, S. Masone
Department of Advanced Biomedical Sciences, University of Naples “Federico II”, Naples, Italy; Department of Clinical Medicine and Surgery, University of Naples “Federico II”, Naples, Italy Contributions: (I) Conception and design: N Velotti, N Rocco, A Vitiello, M Musella, S Masone; (II) Administrative support: N Velotti, N Rocco, A Vitiello, M Musella, S Masone; (III) Provision of study materials or patients: N Velotti, G Berardi, M Pontillo; (IV) Collection and assembly of data: N Velotti, N Rocco, A Vitiello, G Berardi, M Pontillo; (V) Data analysis and interpretation: N Velotti, N Rocco, A Vitiello, M Musella, S Masone; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Nunzio Velotti. Department of Advanced Biomedical Sciences, University of Naples “Federico II”, Via Pansini 5, 80131 Naples, Italy. Email: nunzio.velotti@gmail.com.
那不勒斯那不勒斯“费德里科二世”高级生物医学科学部门;那不勒斯的“费德里科二世”、那不勒斯、意大利的税收:(II)行政支持:(III)研究材料或耐心证明:N Velotti, G Berardi, M Pontillo;(四)数据收集与汇总:N Velotti, N Rocco, A Vitiello, G Berardi, M Pontillo;(V)分析和解析数据:N Velotti, N Rocco, A Vitiello, M Musella, S Masone;(VI)手稿写作:所有权威;手稿最终确认:所有权威。他叫南齐奥·维洛蒂。那不勒斯大学“费德里科二世”高级生物医学科学部门,意大利潘西尼5号,80131那不勒斯。电子邮件:南齐奥velotti@gmail。com。
{"title":"Immediate direct-to-implant breast reconstruction with prepectoral vs. subpectoral approach: a narrative review","authors":"N. Velotti, N. Rocco, A. Vitiello, Giovanna Berardi, Martina Pontillo, M. Musella, S. Masone","doi":"10.21037/abs-21-150","DOIUrl":"https://doi.org/10.21037/abs-21-150","url":null,"abstract":"Department of Advanced Biomedical Sciences, University of Naples “Federico II”, Naples, Italy; Department of Clinical Medicine and Surgery, University of Naples “Federico II”, Naples, Italy Contributions: (I) Conception and design: N Velotti, N Rocco, A Vitiello, M Musella, S Masone; (II) Administrative support: N Velotti, N Rocco, A Vitiello, M Musella, S Masone; (III) Provision of study materials or patients: N Velotti, G Berardi, M Pontillo; (IV) Collection and assembly of data: N Velotti, N Rocco, A Vitiello, G Berardi, M Pontillo; (V) Data analysis and interpretation: N Velotti, N Rocco, A Vitiello, M Musella, S Masone; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Nunzio Velotti. Department of Advanced Biomedical Sciences, University of Naples “Federico II”, Via Pansini 5, 80131 Naples, Italy. Email: nunzio.velotti@gmail.com.","PeriodicalId":72212,"journal":{"name":"Annals of breast surgery : an open access journal to bridge breast surgeons across the world","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42687618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Breast-conserving surgery and immediate autologous fat transfer with or without neoadjuvant treatment: indications, technique, cosmetic and oncologic outcomes 保乳手术和立即自体脂肪转移(有或无新辅助治疗):适应症、技术、美容和肿瘤学结果
E. González, Gastón Berman, H. Ursino, Jorgelina Cavallero, M. E. Azar, Martín Ipiña, D. Mansilla, O. Sturla
Head of Mastology Department, Instituto de Oncología “Ángel H Roffo”, Universidad de Buenos Aires, Buenos Aires, Argentina; Head of Breast Unit, Instituto de Oncología “Ángel H Roffo”, Universidad de Buenos Aires, Buenos Aires, Argentina; Staff Physicians, Instituto de Oncología “Ángel H Roffo”, Universidad de Buenos Aires, Buenos Aires, Argentina; Outpatient Clinic, Instituto de Oncología “Ángel H Roffo”, Universidad de Buenos Aires, Buenos Aires, Argentina Contributions: (I) Conception and design: E González; (II) Administrative support: ME Azar; (III) Provision of study materials or patients: H Ursino; (IV) Collection and assembly of data: J Cavallero; (V) Data analysis and interpretation: G Berman; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Eduardo González. Mastology Department, Instituto de Oncología “Ángel H Roffo”, Universidad de Buenos Aires, Buenos Aires, Argentina. Email: egonzalez57@hotmail.com.
阿根廷布宜诺斯艾利斯大学“Angel H Roffo”肿瘤研究所乳腺科主任;阿根廷布宜诺斯艾利斯大学“Angel H Roffo”肿瘤研究所乳腺科主任;阿根廷布宜诺斯艾利斯大学“Angel H Roffo”肿瘤研究所工作人员物理学家;阿根廷布宜诺斯艾利斯大学“Angel H Roffo”肿瘤研究所门诊部贡献:(i)概念和设计:E Gonzalez;(二) 行政支持:我随机;(三) 提供研究材料或患者:H URSINO;(四) 数据收集和汇编:J Cavallero;(五) 数据分析和解释:G Berman;(六) 手写:所有作者;(七) 手稿的最终批准:所有作者。通讯地址:爱德华多·冈萨雷斯。阿根廷布宜诺斯艾利斯大学“Angel H Roffo”肿瘤研究所乳腺科。电子邮件:egonzalez57@hotmail.com.
{"title":"Breast-conserving surgery and immediate autologous fat transfer with or without neoadjuvant treatment: indications, technique, cosmetic and oncologic outcomes","authors":"E. González, Gastón Berman, H. Ursino, Jorgelina Cavallero, M. E. Azar, Martín Ipiña, D. Mansilla, O. Sturla","doi":"10.21037/abs-21-131","DOIUrl":"https://doi.org/10.21037/abs-21-131","url":null,"abstract":"Head of Mastology Department, Instituto de Oncología “Ángel H Roffo”, Universidad de Buenos Aires, Buenos Aires, Argentina; Head of Breast Unit, Instituto de Oncología “Ángel H Roffo”, Universidad de Buenos Aires, Buenos Aires, Argentina; Staff Physicians, Instituto de Oncología “Ángel H Roffo”, Universidad de Buenos Aires, Buenos Aires, Argentina; Outpatient Clinic, Instituto de Oncología “Ángel H Roffo”, Universidad de Buenos Aires, Buenos Aires, Argentina Contributions: (I) Conception and design: E González; (II) Administrative support: ME Azar; (III) Provision of study materials or patients: H Ursino; (IV) Collection and assembly of data: J Cavallero; (V) Data analysis and interpretation: G Berman; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Eduardo González. Mastology Department, Instituto de Oncología “Ángel H Roffo”, Universidad de Buenos Aires, Buenos Aires, Argentina. Email: egonzalez57@hotmail.com.","PeriodicalId":72212,"journal":{"name":"Annals of breast surgery : an open access journal to bridge breast surgeons across the world","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41665025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiation therapy in breast cancer: a narrative review on current standards and future perspectives 癌症放射治疗的现状与展望
O. Kaidar-Person, B. Offersen
: Mastectomy and reconstructive procedures have been refined over the decades, allowing for aesthetic outcomes close to the native breast shape and in symmetry with the contralateral intact breast or even to improve breasts appearance and symmetry. Similarly, improvements in radiation oncology can help reduce treatment related toxicity and improve outcomes. However, postmastectomy radiation therapy (PMRT) is associated with poor cosmetic outcomes and increased rate complications in patients who undergo breast reconstruction. Radiation therapy planning should be guided by disease stage, risk of recurrence, correct definition of the target volumes and treatment objectives. Currently, there are guidelines endorsed by European Society for Radiotherapy and Oncology (ESTRO) for target volume delineation for breast cancer and elective nodal volumes, including after immediate reconstruction. Correct target volume delineation, along with meticulous radiation planning, total dose and fractionation, dose homogeneity, and organs at risk (OAR) doses are significant for reducing radiation-induced toxicity. Currently, tremendous efforts are done by different groups to improve aesthetic outcomes without compromising disease outcomes in breast cancer patients who are candidates for mastectomy and radiation therapy. The current paper summarizes key principles in PMRT, considering new surgical techniques for immediate breast reconstruction and new, partly experimental radiation techniques including future trials and proton beam irradiation.
:几十年来,乳房切除术和重建程序已经得到了改进,可以获得接近自然乳房形状、与对侧完整乳房对称的美学效果,甚至可以改善乳房的外观和对称性。同样,放射肿瘤学的改进可以帮助减少与治疗相关的毒性并改善结果。然而,在接受乳房重建的患者中,乳腺切除术后放射治疗(PMRT)与较差的美容效果和并发症发生率增加有关。放射治疗计划应以疾病分期、复发风险、目标量的正确定义和治疗目标为指导。目前,欧洲放射治疗和肿瘤学会(ESTRO)批准了癌症靶体积划定和选择性淋巴结体积的指南,包括立即重建后的指南。正确的目标体积描绘,以及细致的辐射规划、总剂量和分级、剂量均匀性和危险器官(OAR)剂量,对于降低辐射诱导的毒性具有重要意义。目前,不同的群体正在做出巨大努力,在不影响乳腺癌症患者的疾病结果的情况下改善美观效果,这些患者是乳房切除术和放射治疗的候选者。本文总结了PMRT的关键原理,考虑到即时乳房重建的新手术技术和新的部分实验性辐射技术,包括未来的试验和质子束辐射。
{"title":"Radiation therapy in breast cancer: a narrative review on current standards and future perspectives","authors":"O. Kaidar-Person, B. Offersen","doi":"10.21037/abs-21-16","DOIUrl":"https://doi.org/10.21037/abs-21-16","url":null,"abstract":": Mastectomy and reconstructive procedures have been refined over the decades, allowing for aesthetic outcomes close to the native breast shape and in symmetry with the contralateral intact breast or even to improve breasts appearance and symmetry. Similarly, improvements in radiation oncology can help reduce treatment related toxicity and improve outcomes. However, postmastectomy radiation therapy (PMRT) is associated with poor cosmetic outcomes and increased rate complications in patients who undergo breast reconstruction. Radiation therapy planning should be guided by disease stage, risk of recurrence, correct definition of the target volumes and treatment objectives. Currently, there are guidelines endorsed by European Society for Radiotherapy and Oncology (ESTRO) for target volume delineation for breast cancer and elective nodal volumes, including after immediate reconstruction. Correct target volume delineation, along with meticulous radiation planning, total dose and fractionation, dose homogeneity, and organs at risk (OAR) doses are significant for reducing radiation-induced toxicity. Currently, tremendous efforts are done by different groups to improve aesthetic outcomes without compromising disease outcomes in breast cancer patients who are candidates for mastectomy and radiation therapy. The current paper summarizes key principles in PMRT, considering new surgical techniques for immediate breast reconstruction and new, partly experimental radiation techniques including future trials and proton beam irradiation.","PeriodicalId":72212,"journal":{"name":"Annals of breast surgery : an open access journal to bridge breast surgeons across the world","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49259962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Timing of post mastectomy radiotherapy in immediate or delayed- immediate breast reconstruction: an algorithm to the sentinel first principle 立即或延迟立即乳房重建的乳房切除术后放疗时机:哨兵优先原则的算法
Lisa Ramaut, M. Vanhoeij, M. Hamdi
About one out of eight women will be dealing with breast cancer throughout their life. The prevalence of this disease has jet-fueled breast cancer research, causing an immense leap in treatment modalities over the last decades. A better understanding of the disease, its subtypes, its genome and its treatment strategies has allowed us to evolve from aggressive to targeted, from debulking to breast conserving and from avoiding death to ensuring quality of life after survival. Despite major advances in medical therapy, surgery remains an indispensable step in breast cancer treatment. The novelties in breast conserving surgery and reconstructive surgery have made the treatment more versatile, which allows the oncoplastic team to provide a tailor-made surgical plan for each patient. The treatment regimen must aim for synergism between the different treatment modalities, without compromising either the oncological or reconstructive objective. While adjuvant therapy may downstage the tumor and make breast conservative surgery possible, adjuvant treatments like radiotherapy might also compromise the reconstructive outcome. Most patients who undergo breast conserving surgery are treated with radiotherapy, whereas the indication for postmastectomy radiotherapy (PMRT) is mainly based on tumor stage and the extent of lymph node involvement. Radiotherapy of the breast is indicated after breast conserving surgery for all invasive tumors, most ductal carcinoma in situ and Paget’s disease. It will also be applied when mastectomy margins were not clear from disease or when the tumors appeared to be more than 4 cm in diameter. Locoregional radiotherapy is indicated when nodal disease is confirmed (≥N1) and will be more extensive according to the degree of nodal disease. In patients needing PMRT, the definite reconstruction can be delayed by placing an expander in the mastectomy pocket. Although the consequences of radiotherapy on the autologous reconstructed breast is the subject of discussion, the literature suggests a higher occurrence of fat necrosis, late flap failure and decreased esthetic outcome from radiotherapy after free flap breast reconstruction (1). Since autologous breast reconstruction requires proper organization regarding surgery time and available surgeons, it is not advisable to rely on a preoperative diagnosis to decide whether or not to proceed with an autologous reconstruction. A problem arises in clinical node-negative breast cancer patients, where the definite tumor and nodal staging is not complete until full tumor and sentinel node resection. It is logistically not feasible to foresee both immediate and delayed reconstructive surgery depending on an intraoperative decision. Therefore, the sentinel first principle was introduced in our center. This paper outlines the algorithm applied in our center, in which the sentinel procedure is done in a separate surgery before the mastectomy for definite staging. This method, called the “sentinel fi
大约八分之一的女性将在她们的一生中与乳腺癌作斗争。这种疾病的流行推动了乳腺癌的研究,在过去的几十年里导致了治疗方式的巨大飞跃。对乳腺癌及其亚型、基因组和治疗策略的更好了解,使我们能够从侵略性发展到针对性,从减脂发展到保乳,从避免死亡发展到确保生存后的生活质量。尽管医学治疗取得了重大进展,但手术仍然是乳腺癌治疗中不可或缺的一步。保乳手术和乳房再造手术的创新性使治疗更加多样化,这使得肿瘤整形团队能够为每位患者提供量身定制的手术计划。治疗方案必须以不同治疗方式之间的协同作用为目标,而不损害肿瘤或重建目标。虽然辅助治疗可以降低肿瘤的分期,使乳房保守手术成为可能,但像放疗这样的辅助治疗也可能损害重建的结果。大多数接受保乳手术的患者都接受放射治疗,而乳房切除术后放射治疗(PMRT)的指征主要基于肿瘤分期和淋巴结受累程度。对于所有侵袭性肿瘤,大多数导管原位癌和Paget病,保乳手术后都需要进行乳房放射治疗。当乳房切除边缘与疾病不清楚或肿瘤直径大于4厘米时,也适用该方法。确诊淋巴结病变(≥N1)时应行局部放疗,并根据淋巴结病变程度扩大放疗范围。在需要PMRT的患者中,可以通过在乳房切除术口袋中放置扩张器来延迟确定的重建。尽管放疗对自体乳房重建的影响仍是讨论的主题,但文献表明,游离皮瓣乳房重建后,放疗的脂肪坏死、晚期皮瓣失效和美观效果下降的发生率较高(1)。由于自体乳房重建需要适当的手术时间和可用的外科医生组织,依靠术前诊断来决定是否进行自体重建是不可取的。在临床淋巴结阴性乳腺癌患者中出现的一个问题是,在肿瘤和前哨淋巴结完全切除之前,肿瘤和淋巴结的明确分期并不完整。根据术中决定来预见立即和延迟的重建手术在逻辑上是不可行的。因此,我们中心引入了哨兵优先原则。本文概述了我们中心应用的算法,其中前哨程序在乳房切除术前的单独手术中进行,以确定分期。这种方法被称为“哨点优先程序”,允许肿瘤整形团队决定是否需要立即或延迟立即重建。本文介绍了一种针对该原理的算法,该算法于2017年在我中心引入,并对13个案例进行了回顾。客观社论
{"title":"Timing of post mastectomy radiotherapy in immediate or delayed- immediate breast reconstruction: an algorithm to the sentinel first principle","authors":"Lisa Ramaut, M. Vanhoeij, M. Hamdi","doi":"10.21037/abs-21-51","DOIUrl":"https://doi.org/10.21037/abs-21-51","url":null,"abstract":"About one out of eight women will be dealing with breast cancer throughout their life. The prevalence of this disease has jet-fueled breast cancer research, causing an immense leap in treatment modalities over the last decades. A better understanding of the disease, its subtypes, its genome and its treatment strategies has allowed us to evolve from aggressive to targeted, from debulking to breast conserving and from avoiding death to ensuring quality of life after survival. Despite major advances in medical therapy, surgery remains an indispensable step in breast cancer treatment. The novelties in breast conserving surgery and reconstructive surgery have made the treatment more versatile, which allows the oncoplastic team to provide a tailor-made surgical plan for each patient. The treatment regimen must aim for synergism between the different treatment modalities, without compromising either the oncological or reconstructive objective. While adjuvant therapy may downstage the tumor and make breast conservative surgery possible, adjuvant treatments like radiotherapy might also compromise the reconstructive outcome. Most patients who undergo breast conserving surgery are treated with radiotherapy, whereas the indication for postmastectomy radiotherapy (PMRT) is mainly based on tumor stage and the extent of lymph node involvement. Radiotherapy of the breast is indicated after breast conserving surgery for all invasive tumors, most ductal carcinoma in situ and Paget’s disease. It will also be applied when mastectomy margins were not clear from disease or when the tumors appeared to be more than 4 cm in diameter. Locoregional radiotherapy is indicated when nodal disease is confirmed (≥N1) and will be more extensive according to the degree of nodal disease. In patients needing PMRT, the definite reconstruction can be delayed by placing an expander in the mastectomy pocket. Although the consequences of radiotherapy on the autologous reconstructed breast is the subject of discussion, the literature suggests a higher occurrence of fat necrosis, late flap failure and decreased esthetic outcome from radiotherapy after free flap breast reconstruction (1). Since autologous breast reconstruction requires proper organization regarding surgery time and available surgeons, it is not advisable to rely on a preoperative diagnosis to decide whether or not to proceed with an autologous reconstruction. A problem arises in clinical node-negative breast cancer patients, where the definite tumor and nodal staging is not complete until full tumor and sentinel node resection. It is logistically not feasible to foresee both immediate and delayed reconstructive surgery depending on an intraoperative decision. Therefore, the sentinel first principle was introduced in our center. This paper outlines the algorithm applied in our center, in which the sentinel procedure is done in a separate surgery before the mastectomy for definite staging. This method, called the “sentinel fi","PeriodicalId":72212,"journal":{"name":"Annals of breast surgery : an open access journal to bridge breast surgeons across the world","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41821875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of breast surgery : an open access journal to bridge breast surgeons across the world
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1